The global flunarizine hydrochloride market is anticipated to grow at a significant CAGR during the forecast period. Flunarizine is used in medical practice and supports to improve blood flow. It is a medicine known as a calcium channel blocker and is used in the treatment of dizziness, vertigo and the prevention of migraine. The major factor driving the demand for the flunarizine hydrochloride is the increasing prevalence of migraine across the globe. Moreover, several factors such as increasing consumption of junk food as well as smoking and drinking coupled with hectic and stressful lifestyle cause migraine which drive the flunarizine hydrochloride demand. Additionally, low cost of flunarizine hydrochloride is driving the growth of the market. Furthermore, the ongoing R&D activities related to flunarizine hydrochloride will present new growth opportunities for the growth of the market. However, the growth of the market is hampered due to the adverse effects and the presence of substitutes such as amlodipine in the market.
Some major players in the market include Johnson and Johnson Services, Inc., Cipla Ltd., and Torrent Pharmaceuticals Ltd., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in December 2020, Xenon Pharmaceuticals Inc. announced updates on early Data from a Phase 2 open-label study of xen007 (flunarizine) for treatment-resistant absence seizures and its proprietary and partnered neurology programs at AES2020, the virtual annual meeting of the American Epilepsy Society.
To Request a Sample of our Report on Flunarizine Hydrochloride Market: https://www.omrglobal.com/request-sample/flunarizine-hydrochloride-market
Market Coverage
- The market number available for – 2023-2031
- Base year- 2023
- Forecast period- 2024-2031
Segment Covered-
- By Product
- By Application
Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape- Johnson and Johnson Services, Inc., Cipla Ltd., and Torrent Pharmaceuticals Ltd., among others.
Flunarizine Hydrochloride Market Report by Segment
By Product
- Tablets
- Capsules
By Application
- Hospital
- Clinic
- Others
A full Report of Flunarizine Hydrochloride Market is Available @ https://www.omrglobal.com/industry-reports/flunarizine-hydrochloride-market
Flunarizine Hydrochloride Market Report by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East & Africa
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
